Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease ...

Swiss drugmaker Roche reported better than expected first-half operating profit on Thursday, driven by strong sales of breast ...

The drugmaker’s sales were up 7% at constant currency from the same period last year.

Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...

Swiss pharmaceutical giant Roche is set to explore the potential of its experimental drug, Trontinemab, in delaying or ...

Swiss pharmaceutical company Roche is launching a study to test a new drug that could prevent Alzheimer's in high-risk ...

Swiss pharma major Roche (ROG: SIX) has outlined ambitious plans to accelerate the development of trontinemab, its ...

The trial drug Trontinemab is designed to bypass the blood brain barrier, delivering more treatment directly to the brain.

An English student has been sentenced to seven years’ imprisonment in London for a phishing scam that also claimed victims in ...

The EU, the main trading partner of the Swiss economy, now has at least some legal security, economiesuisse’s Jan Atteslander ...